Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.
Cattedra di Ematologia, Dipartimento Biomedicina e Prevenzione, Università Tor Vergata, Rome, Italy, del.principe@med.uniroma2.it.
Maria Ilaria
MI
Del Principe
Mariagiovanna
M
Cefalo
Francesco
F
Buccisano
Lucia
L
Anemona
Chiara
C
Sarlo
Luigi
L
Di Caprio
Giovanna
G
De Santis
Erica
E
Giacobbi
Luca
L
Maurillo
Massimiliano
M
Postorino
Giovanni
G
Del Poeta
Sergio
S
Amadori
Adriano
A
Venditti
D000375:Aging / Q000473:pathology; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000473:pathology; D020031:Epstein-Barr Virus Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000150:complications* / Q000188:drug therapy* / Q000821:virology; D008297:Male; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab